Last month, the Saskatchewan government announced that a clinical trial into liberation therapy had been cancelled because there weren’t enough participants.
There were 86 planned participants from Saskatchewan -- a province home to one of the highest rates of M.S. sufferers compared to the rest of Canada. The province had committed up to $2.2 million to have its patients participate in the Albany study.
“Our position is still the same as it was when we announced that the Albany trial was ending,” Duncan said.
“We are going to be looking for the next avenue for research that Saskatchewan can be involved in…It may be CCSVI and the Liberation Therapy; it may not be.”
Users browsing this forum: No registered users